• Cybin outlined a corporate reorganization that will rebrand key subsidiaries under the Helus name in early January 2026.
• Cybin US Holdings will change its legal name to Helus US on Jan. 2, 2026.
• Cybin Corp. will be renamed Helus Pharma Corp. on Jan. 5, 2026.
• Cybin International Limited will become Helus International Limited on Jan. 6, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cybin Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001833141-26-000058), on August 14, 2026, and is solely responsible for the information contained therein.